GAL3ST1 Gene

GAL3ST1 — Galactose-3-O-Sulfotransferase 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GAL3ST1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GAL3ST1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Galactose-3-O-Sulfotransferase 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>22q13.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[9512](https://www.ncbi.nlm.nih.gov/gene/9512)</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>[604582](https://omim.org/entry/604582)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000149654](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149654)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q04589](https://www.uniprot.org/uniprot/Q04589)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Sulfotransferase</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Metachromatic leukodystrophy, multiple sclerosis, adrenal leukodystrophy</td>
</tr>
</table>

Introduction

GAL3ST1 — Galactose-3-O-Sulfotransferase 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GAL3ST1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GAL3ST1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Galactose-3-O-Sulfotransferase 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>22q13.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[9512](https://www.ncbi.nlm.nih.gov/gene/9512)</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>[604582](https://omim.org/entry/604582)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000149654](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149654)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q04589](https://www.uniprot.org/uniprot/Q04589)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Sulfotransferase</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Metachromatic leukodystrophy, multiple sclerosis, adrenal leukodystrophy</td>
</tr>
</table>

Introduction

The GAL3ST1 gene (Galactose-3-O-Sulfotransferase 1) encodes cerebroside sulfotransferase (CST), an essential enzyme in the biosynthesis of sulfatides. Sulfatides are sulfated galactocerebrosides that constitute the most abundant sulfolipids in the mammalian nervous system, comprising up to 15% of myelin lipids. GAL3ST1 catalyzes the transfer of a sulfate group from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the C3 hydroxyl position of galactose in galactocerebroside, converting it to sulfatide (3-O-sulfo-galactosylceramide).

The enzyme is absolutely required for normal central nervous system (CNS) and peripheral nervous system (PNS) myelination. Mutations in GAL3ST1 cause metachromatic leukodystrophy (MLD), a fatal autosomal recessive demyelinating disorder characterized by progressive neurological deterioration, motor impairment, and cognitive decline. Beyond its critical role in myelination, GAL3ST1 is involved in immune cell function, kidney development, and has been implicated in cancer metastasis.

```{.infobox .infobox-gene}
```

Gene Structure and Protein

The human GAL3ST1 gene spans approximately 10 kb on chromosome 22q13.33 and contains 8 exons encoding a 423-amino acid type II transmembrane protein localized to the Golgi apparatus.

Enzyme characteristics:

• Substrate: Galactocerebroside (GalCer) + PAPS → Sulfatide (sulfo-GalCer) + PAP
• Location: Golgi lumen, where sulfatide biosynthesis occurs
• Topology: Type II transmembrane protein with N-terminal cytosolic tail, transmembrane domain, and C-terminal catalytic domain facing the Golgi lumen
• Substrate specificity: Highly specific for galactocerebroside; does not accept lactosylceramide or other glycolipids
• Cofactor requirement: PAPS (3'-phosphoadenosine-5'-phosphosulfate) as sulfate donor

Cellular Functions

Sulfatide Biosynthesis

GAL3ST1 catalyzes the final step in sulfatide production:

Myelin Formation and Maintenance

Sulfatides are essential for myelin integrity:

• Myelin lipid composition: Sulfatides comprise 5-15% of myelin lipids (highest in PNS)
• Stability: Sulfatides contribute to myelin membrane stability through electrostatic interactions
• Compaction: Sulfatides participate in the formation of the intraperiod line in compact myelin
• Node of Ranvier: High sulfatide concentration at nodes contributes to sodium channel clustering

Axon-Glia Interactions

Sulfatides mediate critical communications between oligodendrocytes and axons:

• AXONAL support: Sulfatides promote axonal viability and integrity
• Node formation: Proper distribution of sulfatides at nodes of Ranvier is essential for saltatory conduction
• Metabolic coupling: Sulfatides facilitate metabolite exchange between oligodendrocytes and axons
• Axonal transport: Sulfatide deficiency impairs axonal transport

Immune Function

GAL3ST1 is expressed in immune cells and modulates immune responses:

• T cell activation: Sulfatides are ligands for CD1d and influence NKT cell development and function
• Macrophage function: Sulfatide affects macrophage phagocytosis and cytokine production
• Autoimmunity: Sulfatide loss may contribute to autoimmune demyelination

Kidney Function

GAL3ST1 is expressed in kidney tubular cells:

• Tubule development: Required for normal kidney structure and function
• Electrolyte balance: Sulfatides in kidney may influence ion transport
• Disease associations: GAL3ST1 mutations can cause renal abnormalities in MLD

Expression Pattern

GAL3ST1 exhibits tissue-specific expression:

• Brain: Highest expression in white matter, corpus callosum, and cerebellum
• Oligodendrocytes: Strong expression in mature oligodendrocytes
• Kidney: High expression in renal tubules
• Liver: Moderate expression
• Immune cells: Expressed in macrophages, dendritic cells, and some lymphocytes
• Testis: Expressed in Sertoli cells

• White matter: Highest expression in myelinated fiber tracts
• Oligodendrocyte cell bodies: Concentrated in the Golgi apparatus
• Myelin sheaths: Sulfatide is a major myelin component

Disease Associations

Metachromatic Leukodystrophy (MLD)

MLD (OMIM #250100) is an autosomal recessive lysosomal storage disorder caused by GAL3ST1 deficiency:

• Inheritance: Autosomal recessive (both alleles must be mutated)
• Enzymatic deficiency: Loss of cerebroside sulfotransferase activity leads to accumulation of galactocerebroside (sulfatide precursor) and deficiency of sulfatide
• Pathogenesis: Sulfatide accumulation in oligodendrocytes and Schwann cells causes toxic demyelination; sulfatide deficiency in myelin membranes causes structural instability

Clinical features:

• Motor regression (ataxia, spasticity, weakness)
• Cognitive decline
• Peripheral neuropathy
• Optic atrophy
• Seizures in later stages

Multiple Sclerosis

GAL3ST1 and sulfatide metabolism are implicated in MS:

• Demyelination: Sulfatide loss is a hallmark of demyelinating lesions
• Remyelination failure: Failure of oligodendrocyte precursor differentiation may involve sulfatide synthesis defects
• Autoimmunity: Sulfatide-CD1d-NKT cell axis may be relevant to MS pathogenesis

Adrenal Leukodystrophy (ALD)

Sulfatide metabolism is altered in ALD:

• Peroxisomal dysfunction: ALD involves peroxisomal deficiency affecting lipid metabolism
• Myelin vulnerability: Sulfatide-containing myelin is particularly vulnerable
• Therapeutic relevance: Enhancing sulfatide synthesis may be protective

Cancer Metastasis

GAL3ST1 has been implicated in cancer progression:

• Metastasis promotion: Some cancers upregulate GAL3ST1 to generate sulfatides that facilitate migration
• Immune evasion: Sulfatide expression may modulate tumor immune environment
• Therapeutic targeting: GAL3ST1 inhibitors are being explored as anticancer agents

Therapeutic Implications

Multiple therapeutic approaches target GAL3ST1 and sulfatide metabolism:

Research directions:

• Newborn screening: Detection of GAL3ST1 deficiency before symptom onset
• Prenatal diagnosis: Family planning for at-risk couples
• Biomarkers: Sulfatide/galactocerebroside ratio as disease marker

Key Publications

See Also

• [Metachromatic leukodystrophy](/diseases/metachromatic-leukodystrophy)
• [Sulfatide metabolism in the brain](/mechanisms/sulfatide-metabolism)
• [Myelin biology](/mechanisms/myelin-biology)
• [Oligodendrocyte function](/cell-types/oligodendrocytes)
• [Lysosomal storage disorders](/diseases/lysosomal-storage-disorders)
• [Arylsulfatase A](/proteins/arylsulfatase-a)
• [UGT8](/genes/ugt8)
• [Leukodystrophies](/diseases/leukodystrophies)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving GAL3ST1 Gene discovered through SciDEX knowledge graph analysis: